| 001 | 144608 | ||
| 005 | 20240229112631.0 | ||
| 024 | 7 | _ | |a 10.1038/s41375-019-0395-y |2 doi |
| 024 | 7 | _ | |a pmid:30728457 |2 pmid |
| 024 | 7 | _ | |a 0887-6924 |2 ISSN |
| 024 | 7 | _ | |a 1476-5551 |2 ISSN |
| 024 | 7 | _ | |a altmetric:55169906 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2019-02050 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schlenk, R. F. |0 P:(DE-HGF)0 |b 0 |e First author |
| 245 | _ | _ | |a Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. |
| 260 | _ | _ | |a London |c 2019 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1566567021_407 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Weber, D. |b 1 |
| 700 | 1 | _ | |a Herr, W. |b 2 |
| 700 | 1 | _ | |a Wulf, G. |b 3 |
| 700 | 1 | _ | |a Salih, H. R. |b 4 |
| 700 | 1 | _ | |a Derigs, H. G. |b 5 |
| 700 | 1 | _ | |a Kuendgen, A. |b 6 |
| 700 | 1 | _ | |a Ringhoffer, M. |b 7 |
| 700 | 1 | _ | |a Hertenstein, B. |b 8 |
| 700 | 1 | _ | |a Martens, U. M. |b 9 |
| 700 | 1 | _ | |a Grießhammer, M. |b 10 |
| 700 | 1 | _ | |a Bernhard, H. |b 11 |
| 700 | 1 | _ | |a Krauter, J. |b 12 |
| 700 | 1 | _ | |a Girschikofsky, M. |b 13 |
| 700 | 1 | _ | |a Wolf, D. |b 14 |
| 700 | 1 | _ | |a Lange, E. |b 15 |
| 700 | 1 | _ | |a Westermann, J. |b 16 |
| 700 | 1 | _ | |a Koller, E. |b 17 |
| 700 | 1 | _ | |a Kremers, S. |b 18 |
| 700 | 1 | _ | |a Wattad, M. |b 19 |
| 700 | 1 | _ | |a Heuser, M. |b 20 |
| 700 | 1 | _ | |a Thol, F. |b 21 |
| 700 | 1 | _ | |a Göhring, G. |b 22 |
| 700 | 1 | _ | |a Haase, D. |b 23 |
| 700 | 1 | _ | |a Teleanu, V. |b 24 |
| 700 | 1 | _ | |a Gaidzik, V. |b 25 |
| 700 | 1 | _ | |a Benner, A. |0 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |b 26 |u dkfz |
| 700 | 1 | _ | |a Döhner, K. |b 27 |
| 700 | 1 | _ | |a Ganser, A. |b 28 |
| 700 | 1 | _ | |a Paschka, P. |b 29 |
| 700 | 1 | _ | |a Döhner, H. |b 30 |
| 773 | _ | _ | |a 10.1038/s41375-019-0395-y |g Vol. 33, no. 8, p. 1923 - 1933 |0 PERI:(DE-600)2008023-2 |n 8 |p 1923 - 1933 |t Leukemia |v 33 |y 2019 |x 1476-5551 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:144608 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 26 |6 P:(DE-He78)e15dfa1260625c69d6690a197392a994 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b LEUKEMIA : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b LEUKEMIA : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l Biostatistik |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::